前列腺癌患者18F-氟环丁羧酸PET/CT偶然检出表现为前纵隔肿块的肺腺癌
一例71岁高危原发性前列腺癌(Gleason评分9,前列腺特异性抗原34 ng/mL)患者,在临床试验(NCT03081884)术前18F-氟环丁羧酸PET/CT中,除前列腺局部异常摄取伴包膜外延伸外,偶然发现2.2×1.8 cm前纵隔肿块伴异常放射性示踪剂摄取,活检证实为浸润性肺腺癌(实性及腺泡型,PD-L1高表达)。
要点
- 18F-氟环丁羧酸PET/CT在前列腺癌评估中可偶然检出前列腺外恶性肿瘤。
- 前纵隔肿块伴异常摄取经活检证实为浸润性肺腺癌。
- 该病例提示18F-氟环丁羧酸PET/CT在前列腺癌以外的恶性肿瘤中具有潜在应用价值。
核心结论
- 18F-氟环丁羧酸PET/CT在前列腺癌患者中偶然检出了表现为前纵隔肿块的肺腺癌。
研究设计与样本
- 病例报告:一例71岁高危原发性前列腺癌患者,作为临床试验(NCT03081884)的一部分行术前18F-氟环丁羧酸PET/CT。
主要发现
- 前列腺癌为高危:Gleason评分9,前列腺特异性抗原34 ng/mL。
- 18F-氟环丁羧酸PET/CT显示前列腺内局限性异常摄取伴包膜外延伸。
- 偶然发现前纵隔肿块,大小2.2×1.8 cm,伴异常放射性示踪剂摄取。
- 纵隔肿块活检证实为浸润性肺腺癌,呈实性和腺泡型,程序性死亡配体1高表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
F-fluciclovine is a PET radiotracer approved for detection of recurrent prostate cancer, with utility in other malignancies being investigated. We present the case of a 71-year-old man with high-risk primary prostate cancer (Gleason score 9, prostate-specific antigen 34 ng/mL) and newly diagnosed lung adenocarcinoma. As part of a clinical trial (NCT03081884), preoperative F-fluciclovine PET/CT showed localized abnormal uptake in the prostate gland with extracapsular extension. Additionally, an incidental anterior mediastinal mass measuring 2.2 × 1.8 cm demonstrated abnormal radiotracer uptake. Biopsy of the mediastinal mass confirmed invasive lung adenocarcinoma with solid and acinar patterns and high programmed death 1 ligand expression.
引用
- Abiodun-Ojo OA, Akintayo AA, Sica GL, et al. Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer. Clin Nucl Med. 2020. PMID: 32701811. doi:10.1097/RLU.0000000000003207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。